Edgewise Therapeutics, Inc.
2021 Q2 - 2025 Q4 (19 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 1,250 | 0.0% | 50,392 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 824 | 0.0% | 50,793 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 483 | 0.0% | 36,878 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 793 | 0.0% | 36,028 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 1,005 | 0.0% | 37,638 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 1,012 | 0.0% | 37,927 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 704 | 0.0% | 39,110 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 665 | 0.0% | 36,467 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 324 | 0.0% | 29,620 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 54 | 0.0% | 9,441 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 110 | 0.0% | 14,233 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 94 | 0.0% | 14,092 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 135 | 0.0% | 15,132 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 115 | 0.0% | 11,733 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 101 | 0.0% | 12,712 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 161 | 0.0% | 16,617 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 322 | 0.0% | 21,104 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 110 | 0.0% | 6,624 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 363 | 0.0% | 17,031 | 6/30/2021 |